Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death worldwide, which lacks effective inhibition of progression and metastasis in the advanced clinical stage. Mesoporous silica nanoparticle (MSN)–based cytotoxic or immunoregulatory drug–loading strategies have attracted wid...
Main Authors: | Han Wu, Xin-Fei Xu, Jia-Qi Zhu, Ming-Da Wang, Chao Li, Lei Liang, Hao Xing, Meng-Chao Wu, Feng Shen, Dong-Sheng Huang, Tian Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.695635/full |
Similar Items
-
A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol
by: Cuiyan Han, et al.
Published: (2019-05-01) -
Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy
by: Thashini Moodley, et al.
Published: (2021-01-01) -
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
by: Yaoye Tao, et al.
Published: (2020-03-01) -
Mesoporous silica/polymer nanocomposites
by: Liu, Yi
Published: (2010) -
MESOPOROUS SILICA MATERIALS IN ASYMMETRIC CATALYSIS AND SELECTIVE FUNCTIONALIZATION
by: Seki, Tomohiro
Published: (2013)